{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:18:35Z","timestamp":1781673515094,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":2668,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organization for Health Research and Development","doi-asserted-by":"crossref","award":["150020013"],"award-info":[{"award-number":["150020013"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Foundation of Pediatric Cancer Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1093\/annonc\/mdr595","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T07:00:11Z","timestamp":1328598011000},"page":"2191-2198","source":"Crossref","is-referenced-by-count":52,"title":["The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors"],"prefix":"10.1016","volume":"23","author":[{"given":"E.","family":"Sieswerda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.C.","family":"van Dalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.H.","family":"van der Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J.E.","family":"Tissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.J.","family":"Rammeloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.E.M.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.E.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.N.","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.C.M.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdr595_bb0010","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1001\/jama.297.24.2705","article-title":"Medical assessment of adverse health outcomes in long-term survivors of childhood cancer","volume":"297","author":"Geenen","year":"2007","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdr595_bb0015","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdr595_bb0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/pbc.20613","article-title":"Long-term follow-up of childhood cancer survivors: future directions for clinical care and research","volume":"46","author":"Bhatia","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1093\/annonc\/mdr595_bb0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3322\/canjclin.54.4.208","article-title":"Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors","volume":"54","author":"Oeffinger","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1093\/annonc\/mdr595_bb0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(06)70724-0","article-title":"Long-term follow-up of people who have survived cancer during childhood","volume":"7","author":"Skinner","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdr595_bb0035","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2008.21.1425","article-title":"Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study","volume":"27","author":"Armstrong","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr595_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-125-1-199607010-00008","article-title":"Anthracycline-induced cardiotoxicity","volume":"125","author":"Shan","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdr595_bb0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ctrv.2005.03.008","article-title":"Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review","volume":"31","author":"van der Pal","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"10.1093\/annonc\/mdr595_bb0050","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/annonc\/mdf167","article-title":"Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review","volume":"13","author":"Kremer","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr595_bb0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/annonc\/mdf118","article-title":"Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review","volume":"13","author":"Kremer","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr595_bb0060","doi-asserted-by":"crossref","first-page":"b4606","DOI":"10.1136\/bmj.b4606","article-title":"Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort","volume":"339","author":"Mulrooney","year":"2009","journal-title":"BMJ"},{"key":"10.1093\/annonc\/mdr595_bb0065","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1016\/j.ejca.2006.08.005","article-title":"Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study","volume":"42","author":"van Dalen","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdr595_bb0070","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/archinternmed.2010.233","article-title":"Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study","volume":"170","author":"van der Pal","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1093\/annonc\/mdr595_bb0075","unstructured":"Children's Oncology GroupLong-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancers, Version 3.0 Arcadia, CA. October 2006www.survivorshipguidelines.org (10 April 2011, date last accessed)"},{"key":"10.1093\/annonc\/mdr595_bb0080","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN)Long-Term Follow Up Care of Survivors of Childhood Cancer 2004: Guideline no. 76www.sign.ac.uk\/pdf\/sign76.pdf (10 April 2011, date last accessed)"},{"key":"10.1093\/annonc\/mdr595_bb0085","unstructured":"United Kingdom Children's Cancer Study Group LEG2Therapy Based Long Term Follow Up: A Practice Statement, 2nd editionwww.ukccsg.org (10 April 2011, date last accessed)"},{"key":"10.1093\/annonc\/mdr595_bb0090","series-title":"Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach","author":"Schwartz","year":"2005"},{"key":"10.1093\/annonc\/mdr595_bb0095","series-title":"Late Effects of Childhood Cancer","author":"Wallace","year":"2004"},{"key":"10.1093\/annonc\/mdr595_bb0100","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ctrv.2009.08.010","article-title":"Quality of systematic reviews in pediatric oncology\u2014a systematic review","volume":"35","author":"Lundh","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1093\/annonc\/mdr595_bb0105","first-page":"2057","article-title":"[Evidence-based guideline development in the Netherlands: the EBRO platform]","volume":"148","author":"Burgers","year":"2004","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1093\/annonc\/mdr595_bb0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.bjc.6601904","article-title":"Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy","volume":"91","author":"Pein","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdr595_bb0115","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2001.19.7.1926","article-title":"Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group","volume":"19","author":"Green","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr595_bb0120","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1200\/JCO.2004.09.109","article-title":"Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy","volume":"22","author":"Adams","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr595_bb0125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ejca.2003.12.006","article-title":"Cumulative incidence and risk factors of mitoxantrone-induced cardiotoxicity in children: a systematic review","volume":"40","author":"van Dalen","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdr595_bb0130","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/cncr.11274","article-title":"Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study","volume":"97","author":"Sorensen","year":"2003","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdr595_bb0135","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2006.09.7451","article-title":"Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors","volume":"25","author":"Hudson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr595_bb0140","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJM199506293322602","article-title":"Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer","volume":"332","author":"Lipshultz","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdr595_bb0145","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1200\/JCO.2005.12.121","article-title":"Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia","volume":"23","author":"Lipshultz","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr595_bb0150","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/pbc.22664","article-title":"Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies","volume":"55","author":"Schellong","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1093\/annonc\/mdr595_bb0155","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.ejca.2006.04.014","article-title":"Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines","volume":"42","author":"van Dalen","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdr595_bb0160","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1067\/S0002-9378(03)00837-8","article-title":"Pregnancy outcome in women treated with doxorubicin for childhood cancer","volume":"189","author":"Bar","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1093\/annonc\/mdr595_bb0165","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/annonc\/mdl156","article-title":"Long-term cardiac follow-up in survivors of a malignant bone tumour","volume":"17","author":"Brouwer","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr595_bb0170","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1200\/JCO.2003.08.050","article-title":"Long-term prospective follow-up study of cardiac function after cardiotoxic therapy for malignancy in children","volume":"21","author":"Poutanen","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr595_bb0175","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.ejca.2007.06.012","article-title":"Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review","volume":"43","author":"Bryant","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdr595_bb0180","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators","volume":"327","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdr595_bb0185","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0735-1097(96)00163-5","article-title":"Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction","volume":"28","author":"Giannuzzi","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1093\/annonc\/mdr595_bb0190","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(03)13501-5","article-title":"Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study","volume":"361","author":"Jong","year":"2003","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdr595_bb0195","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group","volume":"333","author":"Kober","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdr595_bb0200","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/0002-9149(92)90052-Z","article-title":"Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study)","volume":"70","author":"Lauer","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1093\/annonc\/mdr595_bb0205","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/S0735-1097(03)01057-X","article-title":"Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study","volume":"42","author":"Lewis","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1093\/annonc\/mdr595_bb0210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/heart.86.1.21","article-title":"Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population","volume":"86","author":"McDonagh","year":"2001","journal-title":"Heart"},{"key":"10.1093\/annonc\/mdr595_bb0215","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdr595_bb0220","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.CIR.0000085166.44904.79","article-title":"Natural history of asymptomatic left ventricular systolic dysfunction in the community","volume":"108","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"10.1093\/annonc\/mdr595_bb0225","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2004.06.022","article-title":"Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines","volume":"22","author":"Silber","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr595_bb0230","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdr595_bb0235","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0735-1097(98)00675-5","article-title":"Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction","volume":"33","author":"Exner","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1093\/annonc\/mdr595_bb0240","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0735-1097(96)00489-5","article-title":"Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators","volume":"29","author":"Vantrimpont","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1093\/annonc\/mdr595_bb0245","first-page":"506","article-title":"Peripartum heart failure in a patient treated previously with doxorubicin","volume":"71","author":"Davis","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1093\/annonc\/mdr595_bb0250","first-page":"399","article-title":"Peripartum cardiomyopathy occurring in a patient previously treated with doxorubicin","volume":"314","author":"Katz","year":"1997","journal-title":"Am J Med Sci"},{"key":"10.1093\/annonc\/mdr595_bb0255","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.amjcard.2007.01.041","article-title":"Prevalence and prognosis of asymptomatic left ventricular diastolic dysfunction in ambulatory patients with coronary heart disease","volume":"99","author":"Ren","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1093\/annonc\/mdr595_bb0260","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/hrt.2003.027516","article-title":"Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function","volume":"90","author":"Dorup","year":"2004","journal-title":"Heart"},{"key":"10.1093\/annonc\/mdr595_bb0265","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0002-9149(97)89179-5","article-title":"Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions","volume":"77","author":"van Royen","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1093\/annonc\/mdr595_bb0270","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1445-5994.2007.01454.x","article-title":"Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction","volume":"38","author":"Ewald","year":"2008","journal-title":"Intern Med J"},{"key":"10.1093\/annonc\/mdr595_bb0275","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clinbiochem.2007.08.016","article-title":"Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care","volume":"41","author":"Hill","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1093\/annonc\/mdr595_bb0280","unstructured":"SKION LATERRichtlijn follow-up na kinderkanker-meer dan 5 jaar na diagnose. Aanbevelingen 16-03-2010Den Haag\/Amsterdam, The NetherlandsSKION2011"},{"key":"10.1093\/annonc\/mdr595_bb0285","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.1542\/peds.2007-0575","article-title":"Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group","volume":"121","author":"Shankar","year":"2008","journal-title":"Pediatrics"},{"key":"10.1093\/annonc\/mdr595_bb0290","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2105\/AJPH.2007.124446","article-title":"Alternatives to the randomized controlled trial","volume":"98","author":"West","year":"2008","journal-title":"Am J Public Health"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419381050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419381050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/23\/8\/2191\/13787720\/mdr595.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T09:37:17Z","timestamp":1624441037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419381050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0923753419381050"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdr595","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}